secwatch.observer — SEC 8-K summary
======================================

Issuer:     OS Therapies Inc (OSTX)
CIK:        0001795091
Form:       8-K
Filed at:   2025-09-02T23:59:59+00:00
Accession:  0001213900-25-083396
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OS Therapies completes warrant inducement, raises $3.8M; extends funding into 2027
--------------------------------------------------------------------------------

- Raised ~$3.78M gross from exercise of 3,373,043 existing warrants at $1.12; issued new warrants at $3.00 exercise price.
- New warrants have forced exercise provision if stock trades above $9.00 for 20 consecutive days; could provide over $20M.
- Proceeds to accelerate OST-HER2 commercial launch for pulmonary metastatic osteosarcoma; company funded into 2027.
- Removal of old $1.12 warrants reduces potential short selling activity, per CEO Paul Romness.
- Offering completed with all remaining holders; substantially similar to prior inducement offers in June/July 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1795091/000121390025083396/0001213900-25-083396-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1795091/000121390025083396/ea0255568-8k_ostherap.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-083396

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer